As of 2026-03-23, the EV/EBITDA ratio of Global Blood Therapeutics Inc (GBT) is -16.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GBT's latest enterprise value is 4,942.22 mil USD. GBT's TTM EBITDA according to its financial statements is -293.25 mil USD. Dividing these 2 quantities gives us the above GBT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 23.7x | 13.8x |
| Forward P/E multiples | 14.5x - 34.6x | 24.7x |
| Fair Price | (67.95) - (107.93) | (88.42) |
| Upside | -199.2% - -257.6% | -229.1% |
| Date | EV/EBITDA |